Delivery Order SPE2DB22D3004-SPE2DB25FSE64
- Not listed
- The Defense Logistics Agency awarded a $11,624.35 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Lorbrena 100 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 21, 2025. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,624.35 to AmerisourceBergen Drug Corp for the supply of Lorbrena 100 mg tablets (30-count units) with an ultimate completion date of August 19, 2025. This is a firm fixed price contract with no set-aside designation, awarded competitively on July 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Lorbrena 100 mg tablets in quantities of 30. This firm fixed-price delivery order, valued at $11,624.35, represents a competitive award with no set-aside designation and is scheduled for completion by September 16, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $11,624.35 to AmerisourceBergen Drug Corp for 30-count tablets of Lorbrena 100 mg, with an ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Lorbrena 100mg tablets in quantities of 30 units. This firm fixed price delivery order, valued at $23,248.70, is scheduled for completion by August 11, 2025, with performance to be executed at the contractor's Conshohocken, Pennsylvania location. The award was made on a competitive basis with no set-aside designation, reflecting the contractor's...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading global pharmaceutical distribution company. The contract, valued at $10,578.39, is for the delivery of 4564002715 - LORBRENA 100 MG TABLET 30S, a specialty pharmaceutical product. The award has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,688.62 firm fixed-price delivery order is for the supply of LORBRENA 100MG TAB 30S, a pharmaceutical product. The contract has an ultimate completion date of April 23, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,688.62 firm fixed-price delivery order contract provides LORBRENA 100 MG TABLET 30S, a specialty pharmaceutical product, with a period of performance through February 28, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp's Corporate Office Division. The $10,965.33 Firm Fixed Price Delivery Order is for the supply of 4,564,361,949 units of the pharmaceutical product LORBRENA 100 MG TABLET 30S, with a completion date of May 13, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at up to $10,965.33, is for the delivery of 4,564,294,649 tablets of the drug Lorbrena (100 mg) to the government. Amerisourcebergen Drug Corp, through its Corporate Office Division, holds a single-award Indefinite Delivery Contract (IDC) with DLA...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSE64Delivery Order
The Defense Logistics Agency awarded a $11,624.35 delivery order to AmerisourceBergen Drug Corp for the supply of Lorbrena 100 mg tablets (30-count packages) under a firm fixed-price contract. The delivery order is scheduled for completion by September 18, 2025, and will be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania facility. This award was competitively awarded with no set-aside designation, reflecting the vendor's capability to meet federal pharmaceutical procurement requirements through open competition. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor serving federal healthcare systems, AmerisourceBergen supplies a wide range of medications and medical supplies to support military and veteran healthcare programs. The DLA Medical Supply Chain relies on such prime vendor relationships to ensure consistent availability of critical pharmaceutical commodities across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.6k | 8/27/25 |